- Joined
- Nov 5, 2007
- Messages
- 116
- Reaction score
- 1
Very interesting...
June 7 (Bloomberg) -- Walgreen Co., the largest U.S. drugstore chain, said it will no longer participate in new or renewed prescription drug plans awarded to CVS Caremark Corp.'s pharmacy benefit manager. CVS dropped the most in seven months.
The partnership isn't in the best interest of customers, pharmacists or shareholders, the Deerfield, Illinois-based company said today in a statement. Current agreements won't be affected. Eileen Howard Dunn, a spokeswoman for CVS, didn't immediately return a call seeking comment.
Walgreen, which operates more than 7,500 stores across the U.S., cited the unpredictability of reimbursement rates and a lack of communication over the transfer of prescription drug plans. The move may hurt CVS as the company strives to renegotiate agreements, according to Gabelli & Co.'s Jeff Jonas.
"The timing's opportunistic," said the analyst at Rye, New York-based Gabelli. "We're getting into the final selling season for 2011 drug plans, and this creates a lot of uncertainty and a lot disruption." Jonas said the move could prompt him to re- evaluate sales estimates for the companies.
CVS is the largest distributor of prescription drugs in the U.S. Last month, CVS said its business practices are under investigation by 24 states in a probe similar to one started by the U.S. Federal Trade Commission. The states are examining the relationship and practices of CVS and Caremark in the aftermath of their 2007 combination.
Walgreen fell $1.10, or 3.6 percent, to $29.74 at 9:34 a.m. in New York Stock Exchange composite trading. CVS, based in Woonsocket, Rhode Island, declined $3.08, or 9.1 percent, to $30.71. Earlier the shares dropped as low as $29.62, the most since Nov. 5.